These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 10481911
21. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Porter JD, Merriam AP, Hack AA, Andrade FH, McNally EM. Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478 [Abstract] [Full Text] [Related]
22. Nanospan, an alternatively spliced isoform of sarcospan, localizes to the sarcoplasmic reticulum in skeletal muscle and is absent in limb girdle muscular dystrophy 2F. Peter AK, Miller G, Capote J, DiFranco M, Solares-Pérez A, Wang EL, Heighway J, Coral-Vázquez RM, Vergara J, Crosbie-Watson RH. Skelet Muscle; 2017 Jun 06; 7(1):11. PubMed ID: 28587652 [Abstract] [Full Text] [Related]
23. Sarcoglycans in muscular dystrophy. Hack AA, Groh ME, McNally EM. Microsc Res Tech; 2017 Jun 06; 48(3-4):167-80. PubMed ID: 10679964 [Abstract] [Full Text] [Related]
24. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy. Zhu X, Wheeler MT, Hadhazy M, Lam MY, McNally EM. FASEB J; 2002 Jul 06; 16(9):1096-8. PubMed ID: 12039854 [Abstract] [Full Text] [Related]
25. Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly. Zhu X, Hadhazy M, Groh ME, Wheeler MT, Wollmann R, McNally EM. J Biol Chem; 2001 Jun 15; 276(24):21785-90. PubMed ID: 11287429 [Abstract] [Full Text] [Related]
26. Pathological analysis of muscle hypertrophy and degeneration in muscular dystrophy in gamma-sarcoglycan-deficient mice. Sasaoka T, Imamura M, Araishi K, Noguchi S, Mizuno Y, Takagoshi N, Hama H, Wakabayashi-Takai E, Yoshimoto-Matsuda Y, Nonaka I, Kaneko K, Yoshida M, Ozawa E. Neuromuscul Disord; 2003 Mar 15; 13(3):193-206. PubMed ID: 12609501 [Abstract] [Full Text] [Related]
27. Secondary coronary artery vasospasm promotes cardiomyopathy progression. Wheeler MT, Korcarz CE, Collins KA, Lapidos KA, Hack AA, Lyons MR, Zarnegar S, Earley JU, Lang RM, McNally EM. Am J Pathol; 2004 Mar 15; 164(3):1063-71. PubMed ID: 14982859 [Abstract] [Full Text] [Related]
28. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. Sciandra F, Bozzi M, Bianchi M, Pavoni E, Giardina B, Brancaccio A. Ann Ist Super Sanita; 2003 Mar 15; 39(2):173-81. PubMed ID: 14587215 [Abstract] [Full Text] [Related]
29. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice. Peter AK, Miller G, Crosbie RH. J Cell Sci; 2007 Mar 15; 120(Pt 6):996-1008. PubMed ID: 17311848 [Abstract] [Full Text] [Related]
30. Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system. Sabharwal R, Chapleau MW. Exp Physiol; 2014 Apr 15; 99(4):627-31. PubMed ID: 24334334 [Abstract] [Full Text] [Related]
31. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Lancioni A, Rotundo IL, Kobayashi YM, D'Orsi L, Aurino S, Nigro G, Piluso G, Acampora D, Cacciottolo M, Campbell KP, Nigro V. Hum Mol Genet; 2011 Dec 01; 20(23):4644-54. PubMed ID: 21890494 [Abstract] [Full Text] [Related]
32. Sarcoglycan complex: implications for metabolic defects in muscular dystrophies. Groh S, Zong H, Goddeeris MM, Lebakken CS, Venzke D, Pessin JE, Campbell KP. J Biol Chem; 2009 Jul 17; 284(29):19178-82. PubMed ID: 19494113 [Abstract] [Full Text] [Related]
33. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart. Ishimaru K, Miyagawa S, Fukushima S, Saito A, Sakai Y, Ueno T, Sawa Y. J Thorac Cardiovasc Surg; 2013 Dec 17; 146(6):1516-25. PubMed ID: 24229503 [Abstract] [Full Text] [Related]
34. Formation of sarcoglycan complex with differentiation in cultured myocytes. Noguchi S, Wakabayashi E, Imamura M, Yoshida M, Ozawa E. Eur J Biochem; 2000 Feb 17; 267(3):640-8. PubMed ID: 10651799 [Abstract] [Full Text] [Related]
35. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, Hanaoka F. Proc Natl Acad Sci U S A; 1997 Dec 09; 94(25):13873-8. PubMed ID: 9391120 [Abstract] [Full Text] [Related]
36. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan. Shi W, Chen Z, Schottenfeld J, Stahl RC, Kunkel LM, Chan YM. Muscle Nerve; 2004 Mar 09; 29(3):409-19. PubMed ID: 14981741 [Abstract] [Full Text] [Related]
37. The sarcoglycan-sarcospan complex localization in mouse retina is independent from dystrophins. Fort P, Estrada FJ, Bordais A, Mornet D, Sahel JA, Picaud S, Vargas HR, Coral-Vázquez RM, Rendon A. Neurosci Res; 2005 Sep 09; 53(1):25-33. PubMed ID: 15993965 [Abstract] [Full Text] [Related]
38. [The frequency of patients with adhalin deficiency in a muscular dystrophy patient population]. Hayashi YK, Arahata K. Nihon Rinsho; 1997 Dec 09; 55(12):3165-8. PubMed ID: 9436429 [Abstract] [Full Text] [Related]
40. Use of western immunoblot for evaluation of myocardial dystrophin, alpha-sarcoglycan, and beta-dystroglycan in dogs with idiopathic dilated cardiomyopathy. Spier AW, Meurs KM, Coovert DD, Lehmkuhl LB, O'Grady MR, Freeman LM, Burghes AH, Towbin JA. Am J Vet Res; 2001 Jan 09; 62(1):67-71. PubMed ID: 11197563 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]